N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N. Cas: 211914-50-0
Catalogue Number | XD93257 |
Product Name | N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N. |
CAS | 211914-50-0 |
Formulae hypotheticaela | C27H30ClN7O3 |
M. Pondus | 482.53 |
Repono Details | Ambiens |
Product Specification
Aspectus | Pulvis albus |
Assay | 99% min |
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochlorideN -[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-b hydrochloride eta-alanine ethyl ester
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride organicum compositum complexus est.Etsi singula usus huius compositi specifici, secundum eius structuram et compositionem, singula praebere non possum, nonnullas applicationes in locis sequentibus habere potest;
Medicamentum evolutionis: Structura mixti nucleum medicamentorum anilineorum et benzimidazolorum continet et cum amino acida (β-alanine) et structurae pyridine iungitur.Huiusmodi structurae possunt exhibere antimicrobialem, antiviralem, antitumorem vel aliam actionem biologicam.Praeterea studia et experimenta adiuvant ut candidatum medicamentorum potentialem suam determinent.
Materiae functiones: Cum haec compositio multiplicem structuram et multiplicem coetus functionem habeat, potentia ad varias materias functiones aedificandas adhiberi potest.Exempli gratia, applicari potest ad materias optoelectricas, materias electronicas organicas vel liquidas materias crystallinas per congruam modificationem et modificationem.
Nota quaeso quod praedicta speculatio tantum est de usu potentiae huius compositi.Imprimis applicationes ulteriores experimenta et studia requirunt ad eorum usum practicum et ad effectum perpendendum.